This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Products
Out-licensing
Out-licensing, different options:
We support your growth - Flexible relationships to ensure your success in the marketplace
In addition to its CDMO services, Unither Pharmaceuticals offers other types of collaboration based on its technological platforms. We offer our partners faster access to the market with turnkey products adapted to the new needs of patients.
By working together, we give you the opportunity to differentiate and expand your product ranges with the main objective of patient comfort and improved compliance.
If you want to develop or manufacture an exhisting or a new product, please contact us. You can also take a look at our product list.
1- License
or transfer of MA
Following the development of in-house products and the compilation of the registration dossiers, we grant licenses on our MAs (marketing authorization) obtained either in DCP (decentralized procedure) or a national repository for a possible extension with a MRP (mutual recognition procedure) depending on market demands or the needs of our partners.
2- Sale of pharmaceutical
dossiers
We can also assign to our partners the rights to the dossiers ready to be submitted for the registration and marketing of products on their territories.
3- Medical devices
In parallel to drugs with an existing MA, we also develop and offer medical devices certified by notified bodies within the European Community.
All our records, MAs, and medical device certifications are intended to be used under license throughout Europe, and in the rest of the world with some adjustments, based on requests from local health authorities.
Whatever the type of partnership set up, we ensure the exclusive production of licensed products.